The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.

AUTOR(ES)

Fick, J

RESUMO

Herpes simplex virus thymidine kinase (HSV-tk)/ganciclovir (GCV) viral-directed enzyme prodrug gene therapy causes potent, tumor-selective cytotoxicity in animal models in which HSV-tk gene transduction is limited to a minority of tumor cells. The passage of toxic molecules from HSV-tk+ cells to neighboring HSV-tk- cells during GCV therapy is one mechanism that may account for this "bystander" cytotoxicity. To investigate whether gap junction-mediated intercellular coupling could mediate this bystander effect, we used a flow cytometry assay to quantitate the extent of heterocellular coupling between HSV-tk+ murine fibroblasts and both rodent and human tumor cell lines. Bystander tumor cytotoxicity during GCV treatment in a coculture assay was highly correlated (P < 0.001) with the extent of gap junction-mediated coupling. These findings show that gap junction-mediated intercellular coupling contributes to the in vitro bystander effect during HSV-tk/GCV therapy and that retroviral transduction of tumor cells is not required for bystander cytotoxicity.

Documentos Relacionados

• Differential regulation of gap junctions by proinflammatory mediators in vitro.
• Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
• Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
• Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro.
• Characterization of inhibition mediated by adenosine in the hippocampus of the rat in vitro.